Key facts
- It has raised $10K; the latest was Later Stage VC in Aug 2025.
- Notable investors include European Innovation Council, Innovationsstarter, Ascenion, BIH Digital Health Accelerator, Capacura — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for TimeTeller
- ·The full record, as it builds
Funding rounds
No funding rounds for TimeTeller are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TimeTeller
Developer of a diagnostic technology designed to determine an individual's circadian rhythm for personalised health optimisation. The company's technology offers a saliva-based test combined with molecular analysis and computational modelling, enabling individuals and patients undergoing medical treatment to improve daily routines and enhance treatment effectiveness with fewer side effects.
- Sector
- Healthcare
- HQ
- Hamburg, Germany
- Founded
- 2015
- Employees
- 4
- Website
- timeteller-health.com/
- Ownership
- Privately Held (backing)
TimeTeller doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TimeTeller shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TimeTeller in its N-PORT filings yet. We sweep new filings monthly.